Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Gastroenterology
Disease Category: Irritable Bowel Syndrome (IBS)

Trial Information

IBS with Constipation

The purpose of this study is to test the effectiveness and safety of an investigational drug called Linaclotide in subjects with irritable bowel syndrome with constipation compared to a placebo. Qualified participants will receive at no cost: Study medication, study-related examinations, laboratory testing, and compensation for time and travel.

Patient Inclusion Criteria:

• Participants must be at least 18 years old.
• Participants must be willing to discontinue any laxatives used before pre-treatment visit in favor of the protocol-defined rescue medication.
• Participants must have unrestricted access to a touch-tone telephone for the duration of the study.

Central Kentucky Research Associates
3475 Richmond Road, 3rd Floor
Lexington, KY 40509
Phone: 859-264-8999 or 1-800-898-1966

View Google Map

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.